
Rheumatology
Latest News

August 19th 2019
By Kelly Davio
Biologics have become the standard of care for rheumatoid arthritis (RA) that fails to respond adequately to conventional disease-modifying antirheumatic agents (DMARDs), and overall, these agents are safe and effective. However, an association between treatment with anti–tumor necrosis factor (anti-TNF) agents and new-onset psoriasis in patients with RA has been observed.
Advertisement
CME Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
3
Adolescents, Young Adults Use AI Chatbots for Mental Health Advice
4
Aligning Incentives Could Increase Access to Lower-Cost Surgery Sites: Xiaoxi Zhao, PhD
5







































































